Dermatomyositis and Graves' disease.
Selva-O'Callaghan
A
A
Mijares-Boeckh-Behrens
T
T
Solans-Laque
R
R
Molins-Vara
T
T
Olivé
G
G
Vilardell-Tarrés
M
M
D013956:Antithyroid Agents / Q000627:therapeutic use; D001262:Atenolol / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use; D003882:Dermatomyositis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006111:Graves Disease / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged; D013960:Thyroid Function Tests
D013956:Antithyroid Agents; D003879:Dermatologic Agents; D005938:Glucocorticoids; D006886:Hydroxychloroquine; D001262:Atenolol; D008713:Methimazole